For citations:
Cherkasova Zh.R., Tsurkan S.A., Prostyakova A.I., Boroda A.M., Rozhkov A.A., Pirogova Yu.N., Nikitina N.M., Sekacheva M.I. Potential clinical application of the cancer antigen CA‑62 for differential diagnosis of prostate cancer and benign prostatic hyperplasia at the elevated prostate‑specific antigen. Research and Practical Medicine Journal. 2023;10(1):10-26. (In Russ.) https://doi.org/10.17709/2410-1893-2023-10-1-1